Autologous CAR T-cell therapies supply chain: challenges and opportunities? (2020)
Attributed to:
FUTURE TARGETED HEALTHCARE MANUFACTURING HUB
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41417-019-0157-z
PubMed Identifier: 31932694
Publication URI: http://europepmc.org/abstract/MED/31932694
Type: Journal Article/Review
Volume: 27
Parent Publication: Cancer gene therapy
Issue: 10-11
ISSN: 0929-1903